MLH1 and cancer: In case of immunohistochemical absence of either MLH1 or PMS2 [10], or demonstrated microsatellite instability, tumor tissue should be tested for biallelic hypermethylation of the MLH1 promotor, which is indicative for sporadic non-LS-associated cancers.